Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

LIBREAST STUDY: Long-term Outcomes After Breast Cancer Liver Metastasis Surgery: an European, Retrospective, Snapshot Study

NCT04817813 is registered in ClinicalTrials.gov with Hospital Miguel Servet as lead sponsor.

NCT NCT04817813
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04817813 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
LIBREAST STUDY: Long-term Outcomes After Breast Cancer Liver Metastasis Surgery: an European, Retrospective, Snapshot Study
Lead sponsor
Hospital Miguel Servet
Phase
Observational
Overall status
Unknown status
Start date
March 15, 2021
Completion date
July 31, 2021
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, liver metastases, surgery